NDC properties for "Cetacaine (benzocaine 14 % / butamben 2 % / tetracaine 2 % ) Mucous Membrane Topical Solution" (RxCUI 543789)
About this data
The tables show NDC propoerties for Cetacaine (benzocaine 14 % / butamben 2 % / tetracaine 2 % ) Mucous Membrane Topical Solution with the RxCUI 543789
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Cetacaine (benzocaine 14 % / butamben 2 % / tetracaine 2 % ) Mucous Membrane Topical Solution (RxCUI 543789)
| MMSL_CODE | BD4040 |
|---|---|
| RxCUI | 543789 |
| SPL_SET_ID | 89f262a4-a41b-41d7-806b-61b9b89542f0 |
| Prescribable Synonym | Cetacaine LIQUID 14 % / 2 % / 2 % Mucous Membrane Topical Solution |
| RXNAV_STR | Cetacaine (benzocaine 14 % / butamben 2 % / tetracaine 2 % ) Mucous Membrane Topical Solution |
| RxNorm Name | benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucous Membrane Topical Solution [Cetacaine] |
| RxNorm Synonym | Cetacaine (benzocaine 14 % / butamben 2 % / tetracaine 2 % ) Mucous Membrane Topical Solution |
| RxNorm Synonym | Cetacaine (benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML) Mucous Membrane Topical Solution |
| Related queries | Interactions (for RxCUI 543789) |
NDC Properties
NDC Item 10223020201
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-1 |
| NDC Item | 10223020201 |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020202
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-2 |
| NDC Item | 10223020202 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-2) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020204
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-4 |
| NDC Item | 10223020204 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-4) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020205
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-5 |
| NDC Item | 10223020205 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-5) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020206
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-6 |
| NDC Item | 10223020206 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-6) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020207
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-7 |
| NDC Item | 10223020207 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-7) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020208
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-8 |
| NDC Item | 10223020208 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-8) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223022501
| NDC 9 | 10223-0225 |
|---|---|
| NDC 10 | 10223-0225-1 |
| NDC Item | 10223022501 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0225-1) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0225 |
NDC Item 10223022601
| NDC 9 | 10223-0226 |
|---|---|
| NDC 10 | 10223-0226-1 |
| NDC Item | 10223022601 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0226-1) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0226 |
NDC Item 10223020201
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-1 |
| NDC Item | 10223020201 |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020202
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-2 |
| NDC Item | 10223020202 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-2) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020204
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-4 |
| NDC Item | 10223020204 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-4) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020205
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-5 |
| NDC Item | 10223020205 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-5) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020206
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-6 |
| NDC Item | 10223020206 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-6) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020207
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-7 |
| NDC Item | 10223020207 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-7) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020208
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-8 |
| NDC Item | 10223020208 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-8) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223022501
| NDC 9 | 10223-0225 |
|---|---|
| NDC 10 | 10223-0225-1 |
| NDC Item | 10223022501 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0225-1) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0225 |
NDC Item 10223022601
| NDC 9 | 10223-0226 |
|---|---|
| NDC 10 | 10223-0226-1 |
| NDC Item | 10223022601 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0226-1) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0226 |
NDC Item 10223020201
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-1 |
| NDC Item | 10223020201 |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020202
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-2 |
| NDC Item | 10223020202 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-2) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020204
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-4 |
| NDC Item | 10223020204 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-4) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020205
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-5 |
| NDC Item | 10223020205 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-5) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020206
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-6 |
| NDC Item | 10223020206 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-6) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020207
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-7 |
| NDC Item | 10223020207 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-7) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020208
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-8 |
| NDC Item | 10223020208 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-8) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223022501
| NDC 9 | 10223-0225 |
|---|---|
| NDC 10 | 10223-0225-1 |
| NDC Item | 10223022501 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0225-1) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0225 |
NDC Item 10223022601
| NDC 9 | 10223-0226 |
|---|---|
| NDC 10 | 10223-0226-1 |
| NDC Item | 10223022601 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0226-1) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0226 |
NDC Item 10223020201
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-1 |
| NDC Item | 10223020201 |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020202
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-2 |
| NDC Item | 10223020202 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-2) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020204
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-4 |
| NDC Item | 10223020204 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-4) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020205
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-5 |
| NDC Item | 10223020205 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-5) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020206
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-6 |
| NDC Item | 10223020206 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-6) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020207
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-7 |
| NDC Item | 10223020207 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-7) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020208
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-8 |
| NDC Item | 10223020208 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-8) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223022501
| NDC 9 | 10223-0225 |
|---|---|
| NDC 10 | 10223-0225-1 |
| NDC Item | 10223022501 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0225-1) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0225 |
NDC Item 10223022601
| NDC 9 | 10223-0226 |
|---|---|
| NDC 10 | 10223-0226-1 |
| NDC Item | 10223022601 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0226-1) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0226 |
NDC Item 10223020201
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-1 |
| NDC Item | 10223020201 |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020202
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-2 |
| NDC Item | 10223020202 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-2) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020204
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-4 |
| NDC Item | 10223020204 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-4) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020205
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-5 |
| NDC Item | 10223020205 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-5) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020206
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-6 |
| NDC Item | 10223020206 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-6) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020207
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-7 |
| NDC Item | 10223020207 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-7) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020208
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-8 |
| NDC Item | 10223020208 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-8) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223022501
| NDC 9 | 10223-0225 |
|---|---|
| NDC 10 | 10223-0225-1 |
| NDC Item | 10223022501 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0225-1) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0225 |
NDC Item 10223022601
| NDC 9 | 10223-0226 |
|---|---|
| NDC 10 | 10223-0226-1 |
| NDC Item | 10223022601 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0226-1) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0226 |
NDC Item 10223020201
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-1 |
| NDC Item | 10223020201 |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020202
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-2 |
| NDC Item | 10223020202 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-2) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020204
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-4 |
| NDC Item | 10223020204 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-4) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020205
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-5 |
| NDC Item | 10223020205 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-5) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020206
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-6 |
| NDC Item | 10223020206 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-6) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020207
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-7 |
| NDC Item | 10223020207 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-7) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020208
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-8 |
| NDC Item | 10223020208 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-8) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223022501
| NDC 9 | 10223-0225 |
|---|---|
| NDC 10 | 10223-0225-1 |
| NDC Item | 10223022501 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0225-1) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0225 |
NDC Item 10223022601
| NDC 9 | 10223-0226 |
|---|---|
| NDC 10 | 10223-0226-1 |
| NDC Item | 10223022601 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0226-1) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0226 |
NDC Item 10223020201
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-1 |
| NDC Item | 10223020201 |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020202
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-2 |
| NDC Item | 10223020202 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-2) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020204
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-4 |
| NDC Item | 10223020204 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-4) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020205
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-5 |
| NDC Item | 10223020205 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-5) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020206
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-6 |
| NDC Item | 10223020206 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-6) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020207
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-7 |
| NDC Item | 10223020207 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-7) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020208
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-8 |
| NDC Item | 10223020208 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-8) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223022501
| NDC 9 | 10223-0225 |
|---|---|
| NDC 10 | 10223-0225-1 |
| NDC Item | 10223022501 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0225-1) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0225 |
NDC Item 10223022601
| NDC 9 | 10223-0226 |
|---|---|
| NDC 10 | 10223-0226-1 |
| NDC Item | 10223022601 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0226-1) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0226 |
NDC Item 10223020201
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-1 |
| NDC Item | 10223020201 |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020202
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-2 |
| NDC Item | 10223020202 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-2) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020204
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-4 |
| NDC Item | 10223020204 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-4) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020205
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-5 |
| NDC Item | 10223020205 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-5) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020206
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-6 |
| NDC Item | 10223020206 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-6) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020207
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-7 |
| NDC Item | 10223020207 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-7) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020208
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-8 |
| NDC Item | 10223020208 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-8) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223022501
| NDC 9 | 10223-0225 |
|---|---|
| NDC 10 | 10223-0225-1 |
| NDC Item | 10223022501 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0225-1) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0225 |
NDC Item 10223022601
| NDC 9 | 10223-0226 |
|---|---|
| NDC 10 | 10223-0226-1 |
| NDC Item | 10223022601 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0226-1) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0226 |
NDC Item 10223020201
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-1 |
| NDC Item | 10223020201 |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020202
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-2 |
| NDC Item | 10223020202 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-2) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020204
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-4 |
| NDC Item | 10223020204 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-4) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020205
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-5 |
| NDC Item | 10223020205 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-5) / 30 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020206
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-6 |
| NDC Item | 10223020206 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0202-6) / 14 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020207
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-7 |
| NDC Item | 10223020207 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-7) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223020208
| NDC 9 | 10223-0202 |
|---|---|
| NDC 10 | 10223-0202-8 |
| NDC Item | 10223020208 |
| Packaging | 1 BOTTLE, GLASS in 1 BOX (10223-0202-8) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0202 |
NDC Item 10223022501
| NDC 9 | 10223-0225 |
|---|---|
| NDC 10 | 10223-0225-1 |
| NDC Item | 10223022501 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0225-1) / 11 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0225 |
NDC Item 10223022601
| NDC 9 | 10223-0226 |
|---|---|
| NDC 10 | 10223-0226-1 |
| NDC Item | 10223022601 |
| Packaging | 1 BOTTLE, GLASS in 1 KIT (10223-0226-1) / 24 g in 1 BOTTLE, GLASS |
| FDA SPL set id | 853725 |
| Labeler | Cetylite Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Marketing effective time low | 1960-01-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_OTHER | N/A |
| Related queries | Properties for NDC 9 10223-0226 |